CF‐associated lung diseases including fibrosis and chronic inflammation became apparent in adult rats at 3.5 months of age following in utero antisense CFTR treatment.12, 13 These data suggest that the rat may represent a useful model to provide further insights into the physiopathology of CF lung disease. Here, CFTR is linked to lung disorder.